| Structure |
Chemical Name |
CAS |
MF |
 |
Irbesartan IMpurity E |
|
C25H28N6O |
 |
LeflunoMide EP IMpurity G |
724429-16-7 |
C12H12N2O2 |
 |
Telmisartan impurity C |
|
|
|
|
Itraconazole iMpurity E |
|
|
 |
Edoxaban Isomer (RRR) |
1255529-24-8 |
C24H30ClN7O4S |
 |
1-NaphthaleneacetaMide, 1,2,3,4-tetrahydro-7-Methoxy- |
92041-01-5 |
C13H17NO2 |
 |
1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid |
112193-75-6 |
C12H24N4O4 |
![7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one](/CAS/GIF/53944-31-3.gif) |
7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one |
53944-31-3 |
C14H11NO2 |
![2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-aMine](/CAS/GIF/612503-08-9.gif) |
2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-aMine |
612503-08-9 |
C12H11N3S |
|
|
IMp. A (EP): 8-Chloro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one |
|
|
|
|
IMp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H- dibenzo[b,e][1,4]diazepine |
|
|
 |
21-Dehydro-16α-hydroxy Prednisolone |
1188271-73-9 |
C21H26O6 |
 |
(6α,11β)-11,20-Dihydroxy-6-Methyl-3-oxopregna-1,4,17(20)-trien-21-al |
1338549-02-2 |
C22H28O4 |
 |
(1R)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol |
1212376-05-0 |
C8H7ClF2O |
![2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol](/CAS/20150408/GIF/376608-75-2.gif) |
2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol |
376608-75-2 |
C17H24ClN5O4S |
 |
Fluconazole IMpurity F |
|
C13H12F2N6O |
 |
Erlotinib IMpurity A |
1058132-82-3 |
C22H25N3O4 |
|
|
Apixaban iMpurity 5 |
|
|
 |
cefaclor iMpurity C |
143059-69-2 |
C15H14ClN3O4S |
|
|
ceftazidiMe iMpurity B |
1236700-64-3 |
|
 |
pidotiMod iMpurity D |
162148-15-4 |
C9H12N2O4S |
 |
Irinotecan Hydroxyl Acid |
142677-15-4 |
C22H22N2O6 |
 |
CyclopropanaMine, 2-(4-fluorophenyl)-(hydrochloride)(1:1),(1R,2S)- |
1314324-00-9 |
C9H11ClFN |
![(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB92667983.gif) |
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
1644461-85-7 |
C23H28F2N6O5S |
|
|
AtracuriuM IMpurity C (Mixture of DiastereoMers) |
86293-35-8 |
|
|
|
AtracuriuM IMpurity E (cis-Quaternary Acid) |
|
|
|
|
AztreonaM IMpurity B |
|
|
|
|
Ceftriaxone IMpurit E |
|
|
 |
Cetirizine IMpurity-6 |
|
C21H25ClN2O3 |
 |
Cinacalcet IMpurity 10 |
1809324-40-0 |
C29H28F3NO2S |
|
|
Dasatinib IMpurity 5 |
|
|
 |
Diacerein IMpurity F |
13928-72-8 |
C35H36O16 |
 |
D-Valganciclovir Hydrochloride |
1393911-57-3 |
C14H23ClN6O5 |
|
|
Entecavir IMpurity E |
|
|
 |
EzetiMibe IMpurity 1 |
190595-66-5 |
C24H22FNO3 |
 |
Flurbiprofen IMpurity B |
1797883-74-9 |
C18H17FO4 |
|
|
IMatinib DiPiperidine IMpurity |
|
|
|
|
levocetirizine IMpurity |
|
|
|
|
OseltaMivir IMpurity F |
|
|
|
|
RocuroniuM BroMide IMpurity 19 |
|
|
 |
S-(+)-O-DesMethyl-Venlafaxine-d6 |
1062609-99-7 |
C16H25NO2 |
 |
SalMeterol IMpurity F |
|
C25H37NO4 |
 |
Sitagliptin Defuoro IMpurity 4 |
486459-98-7 |
C15H19F2NO4 |
|
|
Sulpiride IMpurity F |
|
|
 |
trans-Ibuprofen IMpurity G |
1391054-15-1 |
C26H32O4 |
 |
EthanediaMide iMpurity F |
480452-37-7 |
C16H22ClN5O3 |
|
|
Paroxetine IMpurity |
|
|
![7-[(2-aMinoethyl)aMino] -1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20150408/GIF/CB92679157.gif) |
7-[(2-aMinoethyl)aMino] -1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C14H16FN3O3 |
![(S)-(1R,3s,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl 3-hydroxy-2-phenylpropanoate](/CAS/20150408/GIF/61616-97-5.gif) |
(S)-(1R,3s,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl 3-hydroxy-2-phenylpropanoate |
61616-97-5 |
C17H21NO3 |
 |
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
 |
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
 |
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
 |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
 |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
 |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
 |
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
 |
4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID |
31166-29-7 |
C5H2Cl2O2S |
 |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
|
|
Entacapone |
|
|
 |
nifedipine iMpurity |
|
C19H22N2O6 |
|
|
Linagliptin Impurity A |
|
|
 |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
 |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
|
|
Linagliptin Impurity V |
|
|
 |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
 |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
|
|
Etoricoxib Impurity 18 |
|
|
 |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
|
|
Imatinib Impurity 3 |
|
|
|
|
Mirabegron Impurity 16 |
|
|
|
|
Olaparib Impurity 2 |
|
|
 |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
 |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
|
|
Cinacalcet Impurity 22 |
|
|
|
|
Dapagliflozin Impurity C |
|
|
|
|
Dasatinib Impurity E |
|
|
|
|
Ixazomib Impurity |
|
|
|
|
Nevirapine Impurity |
|
|
 |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
 |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
 |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
|
|
Trifluridine Impurity |
2086328-10-9 |
|
|
|
Valsartan related compound H |
|
|
 |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
|
|
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
 |
Merariveron impurity D |
|
C26H28N6O3S2 |
|
|
Cefazolin impurity E |
|
|
|
|
Lamivudine Impurity Mixture |
|
|
 |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
 |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
 |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
 |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
 |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
 |
Aprepitant EP Impurity B |
2206606-86-0 |
C29H25F7N4O3 |
 |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |
 |
Meloxicam EP Impurity D |
1331636-17-9 |
C16H17N3O4S2 |